Global X - Genomics & Biotechnology (GNOM) ETF Holdings & Analysis
ETFOther
What GNOM does
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| MODERNA INC | 7.50% | |
| TWIST BIOSCIENCE CORP | 6.34% | |
| 10X GENOMICS INC-CLASS A | 5.48% | |
| GUARDANT HEALTH INC | 5.28% | |
| ILLUMINA INC | 4.86% | |
| NATERA INC | 4.60% | |
| GENSCRIPT BIOTECH CORP | 3.81% | |
| VERTEX PHARMACEUTICALS INC | 3.70% | |
| BIO-TECHNE CORP | 3.67% | |
| BIOMARIN PHARMACEUTICAL INC | 3.58% |
Sector allocation
| Healthcare | 99.74% |
| Technology | 0.26% |
Geographic allocation
| Other | -0.02% |
| United States | 83.89% |
| Hong Kong | 3.81% |
| Netherlands | 5.31% |
| Switzerland | 3.00% |
| Germany | 2.78% |
| United Kingdom | 1.23% |
PortView Portfolio Insights
PortView analyzes how GNOM fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze GNOM in PortView →Related securities
Related stocks
Frequently asked questions
- What does GNOM track?
- GNOM is the Global X - Genomics & Biotechnology ETF, a Other ETF.
- What is the expense ratio of GNOM?
- Expense ratio data for GNOM is shown on the page when available from our data provider.
- What are the largest holdings in GNOM?
- Top holdings include MRNA, TWST, TXG, GH, ILMN.
- How can PortView analyze GNOM overlap with other ETFs?
- PortView computes the holdings overlap between GNOM and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.